Publication | Open Access

Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study

Breast OncologyMedicineImmunologyCleopatra StudyPathologyRetrospective AnalysisBreast CancerCancer TreatmentOncologyTumor MicroenvironmentTumour-infiltrating Lymphocytes